Assembled bulk BCR repertoires from longitudinal dengue challenge samples

Access to data from the VLAIO DenMark project “Use of multimodel omics technologies to study Dengue host response markers” is controlled by the VLAIO DenMark Project Data Access Committee. The project is a collaboration between Janssen Pharmaceutica NV, Universiteit Gent, and the Institute of Tropical Medicine Antwerp. Access may be granted to qualified researchers for scientifically justified research use related to dengue infection, host immune response, biomarker discovery, immunological profiling, or related biomedical research. Requests must include a clear research proposal, institutional affiliation, evidence of appropriate ethics approval where applicable, and confirmation that the proposed use is consistent with participant consent and applicable data protection requirements. Approved users must use the data only for the approved research purpose, maintain confidentiality, protect the data using appropriate technical and organisational safeguards, and comply with all applicable laws and institutional policies. Users may not attempt to identify or re-identify participants, may not link the data with other datasets for re-identification purposes, may not redistribute the data to unauthorised third parties, and may not use the data for purposes outside the approved project without renewed DAC approval. Any publication or public communication based on the data must acknowledge the VLAIO DenMark project and the contributing organisations where appropriate, and must not disclose information that could compromise participant privacy or confidentiality. Access may be withdrawn if users breach the approved terms of use.